Hip14l-deficient mice develop neuropathological and behavioural features of Huntington disease - PubMed (original) (raw)
. 2013 Feb 1;22(3):452-65.
doi: 10.1093/hmg/dds441. Epub 2012 Oct 16.
Shaun S Sanders, Stefanie L Butland, Roshni R Singaraja, Sonia Franciosi, Amber L Southwell, Crystal N Doty, Mandi E Schmidt, Katherine K N Mui, Vlad Kovalik, Fiona B Young, Weining Zhang, Michael R Hayden
Affiliations
- PMID: 23077216
- DOI: 10.1093/hmg/dds441
Hip14l-deficient mice develop neuropathological and behavioural features of Huntington disease
Liza M Sutton et al. Hum Mol Genet. 2013.
Abstract
Palmitoylation, the dynamic post-translational addition of the lipid, palmitate, to proteins by Asp-His-His-Cys-containing palmitoyl acyltransferase (PAT) enzymes, modulates protein function and localization and plays a key role in the nervous system. Huntingtin-interacting protein 14 (HIP14), a well-characterized neuronal PAT, has been implicated in the pathogenesis of Huntington disease (HD), a fatal neurodegenerative disease associated with motor, psychiatric and cognitive symptoms, caused by a CAG expansion in the huntingtin gene (HTT). Mice deficient for Hip14 expression develop neuropathological and behavioural features similar to HD, and the catalytic activity of HIP14 is impaired in HD mice, most likely due to the reduced interaction of HIP14 with HTT. Huntingtin-interacting protein 14-like (HIP14L) is a paralog of HIP14, with identical domain structure. Together, HIP14 and HIP14L are the major PATs for HTT. Here, we report the characterization of a Hip14l-deficient mouse model, which develops adult-onset, widespread and progressive neuropathology accompanied by early motor deficits in climbing, impaired motor learning and reduced palmitoylation of a novel HIP14L substrate: SNAP25. Although the phenotype resembles that of the Hip14(-/-) mice, a more progressive phenotype, similar to that of the YAC128 transgenic mouse model of HD, is observed. In addition, HIP14L interacts less with mutant HTT than the wild-type protein, suggesting that reduced HIP14L-dependent palmitoylation of neuronal substrates may contribute to the pathogenesis of HD. Thus, both HIP14 and HIP14L may be dysfunctional in the disease.
Similar articles
- Aberrant palmitoylation in Huntington disease.
Sanders SS, Hayden MR. Sanders SS, et al. Biochem Soc Trans. 2015 Apr;43(2):205-10. doi: 10.1042/BST20140242. Biochem Soc Trans. 2015. PMID: 25849918 Review. - Wild-type HTT modulates the enzymatic activity of the neuronal palmitoyl transferase HIP14.
Huang K, Sanders SS, Kang R, Carroll JB, Sutton L, Wan J, Singaraja R, Young FB, Liu L, El-Husseini A, Davis NG, Hayden MR. Huang K, et al. Hum Mol Genet. 2011 Sep 1;20(17):3356-65. doi: 10.1093/hmg/ddr242. Epub 2011 Jun 2. Hum Mol Genet. 2011. PMID: 21636527 Free PMC article. - Identification of binding sites in Huntingtin for the Huntingtin Interacting Proteins HIP14 and HIP14L.
Sanders SS, Mui KK, Sutton LM, Hayden MR. Sanders SS, et al. PLoS One. 2014 Feb 28;9(2):e90669. doi: 10.1371/journal.pone.0090669. eCollection 2014. PLoS One. 2014. PMID: 24651384 Free PMC article. - Huntingtin interacting proteins 14 and 14-like are required for chorioallantoic fusion during early placental development.
Sanders SS, Hou J, Sutton LM, Garside VC, Mui KK, Singaraja RR, Hayden MR, Hoodless PA. Sanders SS, et al. Dev Biol. 2015 Jan 15;397(2):257-66. doi: 10.1016/j.ydbio.2014.11.018. Epub 2014 Dec 3. Dev Biol. 2015. PMID: 25478910 - Putting proteins in their place: palmitoylation in Huntington disease and other neuropsychiatric diseases.
Young FB, Butland SL, Sanders SS, Sutton LM, Hayden MR. Young FB, et al. Prog Neurobiol. 2012 May;97(2):220-38. doi: 10.1016/j.pneurobio.2011.11.002. Epub 2011 Dec 7. Prog Neurobiol. 2012. PMID: 22155432 Review.
Cited by
- The Golgi S-acylation machinery comprises zDHHC enzymes with major differences in substrate affinity and S-acylation activity.
Lemonidis K, Gorleku OA, Sanchez-Perez MC, Grefen C, Chamberlain LH. Lemonidis K, et al. Mol Biol Cell. 2014 Dec 1;25(24):3870-83. doi: 10.1091/mbc.E14-06-1169. Epub 2014 Sep 24. Mol Biol Cell. 2014. PMID: 25253725 Free PMC article. - The physiology of protein S-acylation.
Chamberlain LH, Shipston MJ. Chamberlain LH, et al. Physiol Rev. 2015 Apr;95(2):341-76. doi: 10.1152/physrev.00032.2014. Physiol Rev. 2015. PMID: 25834228 Free PMC article. Review. - The palmitoyl acyltransferase HIP14 shares a high proportion of interactors with huntingtin: implications for a role in the pathogenesis of Huntington's disease.
Butland SL, Sanders SS, Schmidt ME, Riechers SP, Lin DT, Martin DD, Vaid K, Graham RK, Singaraja RR, Wanker EE, Conibear E, Hayden MR. Butland SL, et al. Hum Mol Genet. 2014 Aug 1;23(15):4142-60. doi: 10.1093/hmg/ddu137. Epub 2014 Apr 4. Hum Mol Genet. 2014. PMID: 24705354 Free PMC article. - Huntingtin and the Synapse.
Barron JC, Hurley EP, Parsons MP. Barron JC, et al. Front Cell Neurosci. 2021 Jun 15;15:689332. doi: 10.3389/fncel.2021.689332. eCollection 2021. Front Cell Neurosci. 2021. PMID: 34211373 Free PMC article. Review. - Regulation of Dynamic Protein S-Acylation.
Chen JJ, Fan Y, Boehning D. Chen JJ, et al. Front Mol Biosci. 2021 Apr 26;8:656440. doi: 10.3389/fmolb.2021.656440. eCollection 2021. Front Mol Biosci. 2021. PMID: 33981723 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous